Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FKELS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,450
Award facts
- Contract value 100% obligated
- $98,449.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $98,449.80 to DMS Pharmaceutical Group Inc. for the supply of Keytruda (pembrolizumab) 100 mg/4 ml vials. The award, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, requires delivery to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, will fulfill this order without the application of a set-aside designation. The company leverages its established relationship with the Defense Logistics Agency through a larger indefinite delivery contract vehicle valued at $499,999,999 and valid through November 2026, which enables the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facilities.
This delivery order represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain. The company's portfolio includes a diverse range of pharmaceutical products—branded and generic prescription drugs, biologics, over-the-counter medications, and specialty items—distributed to Department of Defense healthcare facilities nationwide. As a woman-owned small business registered in SAM.gov since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in meeting federal procurement requirements for complex pharmaceutical products, including oncology treatments and specialized medical supplies, positioning it as a trusted vendor for military healthcare logistics.
Quick answers
Who was awarded contract SPE2DB25FKELS?
SPE2DB25FKELS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FKELS worth?
The government has obligated $98,450 on SPE2DB25FKELS.
Is contract SPE2DB25FKELS an order under another contract?
Yes. SPE2DB25FKELS is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKELS competed?
The extent of competition for SPE2DB25FKELS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award